AADE joined the DAA in submitting letters to HHS Secretary Alex Azar and FDA Commission Scott Gottlieb and CMS Administrator Seema Verma to address concerns with blood glucose testing system accuracy.
AADE took action and sent a letter to CMS after the agency announced their plans to rescind 2012 guidance prohibiting Medicare Advantage Plans from using step therapy to manage costs.
AADE submitted comments to CMS in response to their Competitive Bidding Program (CBP) proposed rule. AADE addressed our concerns with the low pricing for diabetes testing supplies (DTS) under the CBP and the impact this has on quality, availability, and access to DTS for Medicare beneficiaries.
AADE worked with the DAA to submit comments to the U.S. Preventative Services Task Force (USPSTF) to address the Draft Research Plan for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Screening.
AADE submits comments to CMS in response to the Medicare Physician Fee Schedule proposed rule for 2019.
AADE worked with the DAA to submit comments to the U.S. Preventative Services Task Force (USPSTF) to address the Draft Research Plan for Diet and Physical Activity to Prevent Cardiovascular Disease in Adults with Risk Factors: Counseling. View the USPSTF's final research plan on Healthful Diet and Physical Activity to Prevent CVD in Adults with Risk Factors: Behavioral Counseling Interventions
AADE signs on to DAA letter to Director Mick Mulvaney of OMB in response to his comments regarding people with diabetes
AADE Position on Healthcare Reform
AADE's Formal Comments in Response to CMS Proposed Physician Fee Schedule
Press Release: New Report in Diabetes Care Supports AADE Research from 2011
AADE Urges House Energy & Commerce Chairs to Repeal Funding
AADE and DAA Support Funding for National Diabetes Prevention Program
Diabetes Advocacy Organizations Support H.R. 4209 - Minority Diabetes Initiative Act
AADE Letter to Senate Finance Committee on Chronic Care Working Group Policy Options